302 Antitumor Activity of Ficlatuzumab in Combination with Cetuximab On Squamous Cell Carcinomas of the Head and Neck
Meetze, K, Connolly, K, Clark, K, Gyuris, J, Han, M
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
374 Neuregulin 1 (NRG1) expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor models
Meetze, K, Vincent, S, Tyler, S, Mazsa, E, Delpero, A, Bottega, S, McIntosh, D, Gyuris, J, Weng, Z
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
414 The Anti-tumor Activity of the ERBB3 Inhibitory Antibody AV-203 in Patient Derived Tumor Explant Models
Meetze, K, Tyler, S, Clark, K, Mazsa, E, Delpero, A, Gyuris, J, Vincent, S
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
301 Antitumor Activity of Ficlatuzumab in Combination with Tivozanib On Primary Human Renal Cell Carcinoma Xenografts
Meetze, K, Connolly, K, Feng, B, Rideout, W, Gyuris, J, Han, M
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
A family of novel TEAD palmitoylation site inhibitors with exceptional pre-clinical anti-neoplastic activity as a monotherapy and in combination with MAPK inhibitors
Muller, F., Warshaviak, D., Gyuris, J., Nir, R., Baloglu, E., Shacham, S., Morley, A., Depinho, R.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
230 Essential role of fibroblast growth factor receptor 2 (FGFR2) in tumorigenesis of human cancers harboring FGFR2 amplification demonstrated by a functional blocking antibody
Bai, A, Meetze, K, Vo, N, Kollipara, S, Mazsa, E, Winston, W, Weiler, S, Lerner, L, Gyuris, J, Weng, Z
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
2LB Anti-tumor activity of anti-RON antibodies and biomarker of response
Han, M, Whalen, K, Gifford, J, Boudrow, A, Meetze, K, Liu, Q, Feng, B, Winston, W, Weiler, S, Gyuris, J
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
Positive and negative control of nod gene expression in Rhizobium meliloti is required for optimal nodulation
Kondorosi, Eva, Gyuris, Jenö, Schmidt, Jürgen, John, Michael, Duda, Ernö, Hoffmann, Beate, Schell, Jeff, Kondorosi, Adam
Published in The EMBO journal (01.05.1989)
Published in The EMBO journal (01.05.1989)
Get full text
Journal Article
233PPHASE 2 CLINICAL EVALUATION OF PRECLINICALLY DEFINED BIOMARKERS FOR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) TYROSINE KINASE INHIBITOR (TKI) TIVOZANIB IN RENAL CELL CARCINOMA (RCC)
Hutson, T., Rathmell, W.K., Feng, B., Robinson, M.O., Gyuris, J., Lin, J., Choueiri, T.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Phase 2 Clinical Evaluation of Preclinically Defined Biomarkers for Vascular Endothelial Growth Factor (Vegf) Tyrosine Kinase Inhibitor (Tki) Tivozanib in Renal Cell Carcinoma (Rcc)
Hutson, T., Rathmell, W.K., Feng, B., Robinson, M.O., Gyuris, J., Lin, J., Choueiri, T.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Interaction trap/two-hybrid system to identify interacting proteins
Golemis, E A, Serebriiskii, I, Gyuris, J, Brent, R
Published in Current protocols in neuroscience (01.05.2001)
Published in Current protocols in neuroscience (01.05.2001)
Get more information
Journal Article
205PEFFICACY ANALYSIS OF GEFITINIB +/- FICLATUZUMAB IN SERUM PROTEOMIC BASED SUBGROUPS OF PATIENTS WITH PREVIOUSLY UNTREATED LUNG ADENOCARCINOMA
Mok, T.S.K., Tan, E., Greater, S.L., Chang, G., Yang, J.C., Gyuris, J., Han, M., Komarnitsky, P., Payumo, F., Pestano, G., Roder, J., Spinella, D., Weng, Z., Park, K.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Efficacy Analysis of Gefitinib +/- Ficlatuzumab in Serum Proteomic Based Subgroups of Patients with Previously Untreated Lung Adenocarcinoma
Mok, T.S.K., Tan, E., Greater, S.L., Chang, G., Yang, J.C., Gyuris, J., Han, M., Komarnitsky, P., Payumo, F., Pestano, G., Roder, J., Spinella, D., Weng, Z., Park, K.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Conversion of mRNA into double-stranded cDNA
Klickstein, L B, Neve, R L, Golemis, E A, Gyuris, J
Published in Current protocols in molecular biology (Print) (01.05.2001)
Published in Current protocols in molecular biology (Print) (01.05.2001)
Get more information
Journal Article
Interaction trap/two-hybrid system to identify interacting proteins
Golemis, E A, Serebriiskii, I, Finley, Jr, R L, Kolonin, M G, Gyuris, J, Brent, R
Published in Current protocols in protein science (01.05.2001)
Published in Current protocols in protein science (01.05.2001)
Get more information
Journal Article